Johnson & Johnson MedTech has introduced the KINCISE™ 2 Surgical Automated System, a next-generation power tool designed to improve surgical efficiency, provide enhanced control, and reduce the physical burden on orthopaedic surgeons during hip and knee replacement procedures. Now available in the U.S., the system supports both primary and revision hip replacements, as well as revision knee procedures.
Orthopaedic surgeons often face increasing procedural complexity, high case volumes, and physically demanding tasks, such as repeated mallet strikes. These factors contribute to musculoskeletal pain, which affects 97% of orthopaedic surgeons, particularly in the back, neck, and hands. The KINCISE™ 2 System directly addresses these challenges by offering automated impaction technology that reduces repetitive manual effort while enhancing procedural control and consistency.
Dr. Vasilios Mathews, an orthopaedic surgeon at Texas Orthopedic Hospital, stated, “The KINCISE™ 2 System helps surgeons stay at their best, longer. It reduces strain and supports surgical precision, allowing us to focus more on patient outcomes.”
Building on the proven performance of the original KINCISE™ System, this next-generation model introduces several key advancements. These include increased reverse energy, push-to-lock adaptors, and, notably, the first-ever FDA-approved automated system for removing well-fixed acetabular components, expanding its value in complex hip revisions.
“The KINCISE™ 2 System is a clear example of our commitment to needs-based innovation,” said Aldo Denti, Company Group Chairman, Orthopaedics, Johnson & Johnson MedTech. “As the number of joint replacements and revisions grows, surgeons need tools that help reduce operating time and enhance procedural control. The KINCISE™ 2 System meets that need while supporting improved outcomes.”
This launch reflects Johnson & Johnson MedTech’s broader mission to deliver smarter, more adaptive orthopaedic solutions. By integrating cutting-edge technologies into surgical workflows, the company aims to improve performance, standardize care, and elevate the surgical experience for both providers and patients.